Why is Natco Pharma falling/rising?

As of 23-Jul, Natco Pharma Ltd. is experiencing a price increase, with its current price at 1,034.50, reflecting a rise of 17.6 or 1.73%. The stock has shown positive momentum, having outperformed its sector by 1.22% today and achieving a consecutive gain over the last two days with a total return of 1.95%. Additionally, the stock has performed well over the past week, with a return of 1.39%, and a notable 19.19% increase over the past month. Despite a year-to-date decline of 25.41%, the company demonstrates strong fundamentals, including a high return on equity (ROE) of 15.57% and a low debt-to-equity ratio, which contribute to its attractive valuation. The stock is trading at a discount compared to its peers, and its profits have increased by 35.8% over the past year, indicating healthy long-term growth.
In the broader market context, Natco Pharma's short-term performance has significantly outpaced the Sensex, which only increased by 0.11% over the same week. This suggests that investor sentiment towards Natco Pharma is relatively strong compared to the overall market. However, there are signs of falling investor participation, as indicated by a decrease in delivery volume, which could impact future price movements. Despite this, the high institutional holdings at 21.33% indicate confidence from larger investors, who typically have more resources to analyze the company's fundamentals. Overall, while the stock has faced challenges in the longer term, its recent gains reflect positive investor sentiment and strong underlying financial performance.